ERYTECH provides financial update for Q1 2014 admERY May 15, 2014 Newsroom ERYTECH provides a financial update for the first quarter of 2014. You Might Also Like ERYTECH Strengthens Executive Team with the Appointment of Alex Dusek as VP of Commercial Strategy May 14, 2018 ERYTECH to Present Full Results for Phase 2b Trial of eryaspase in Pancreatic Cancer at ESMO 2017 August 31, 2017 ERYTECH announces positive safety review for eryaspase in its Phase 2 study in pancreatic cancer July 20, 2015
ERYTECH Strengthens Executive Team with the Appointment of Alex Dusek as VP of Commercial Strategy May 14, 2018
ERYTECH to Present Full Results for Phase 2b Trial of eryaspase in Pancreatic Cancer at ESMO 2017 August 31, 2017
ERYTECH announces positive safety review for eryaspase in its Phase 2 study in pancreatic cancer July 20, 2015
